Carpineto P

Carpineto P, Toto L, Aloia R, Ciciarelli V, Borrelli E, Vitacolonna E et al.

This study found significant neuroretinal thinning (GC-IPL/RNFL) in type 2 diabetes patients, even without visible retinopathy, suggesting early neuronal damage precedes microvascular changes.

Ciancaglini M, Carpineto P, Agnifili L, Nubile M, Fasanella V, Mattei P A et al.

This study found trabeculectomy with mitomycin C significantly increases conjunctival microcyst density and area, indicating enhanced aqueous filtration post-surgery in glaucoma patients.

Ciancaglini M, Carpineto P, Costagliola C, Matropasqua L

This study found lamina cribrosa blood flow, not neuroretinal rim flow, strongly correlates with visual field damage in glaucoma, highlighting its importance in disease progression.

Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga P E

Latanoprost once daily was more effective than timolol twice daily in reducing intraocular pressure in pigmentary glaucoma, also enhancing outflow facility, offering a superior treatment option.

Mastropasqua L, Carpineto P, Ciancaglini M, Zuppardi E, Lobefalo L, Gallenga P E

Delayed 5-FU with ocular massage effectively salvaged failing trabeculectomy blebs, especially when combined with intraoperative MMC, improving long-term glaucoma control.

Mastropasqua L, Ciancaglini M, Carpineto P, Costagliola C

Topical ketanserin significantly lowered IOP by 19.5% in glaucoma patients uncontrolled on timolol, suggesting it's a safe and effective add-on therapy for better pressure control.

Mastropasqua L, Ciancaglini M, Carpineto P, Lobefalo L, Gallenga P E

Nd:YAG capsulotomy can cause aqueous misdirection (malignant glaucoma), where fluid pockets behind the iris elevate eye pressure. Medical therapy effectively resolved this rare, serious complication.